Literature DB >> 8438895

Cyclosporine A used as a single drug in the treatment of pure red cell aplasia associated with thymoma.

J A Garcia Vela, M C Monteserin, F Oña, L M Barea, A Lastra, V Pérez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8438895     DOI： 10.1002/ajh.2830420229

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

1.  Thymoma with Concomitant Pure Red Cell Aplasia, Good's Syndrome and Myasthenia Gravis Responding to Rituximab.

Authors:  Ahmad I Antar; Zaher K Otrock; Mohamed A Kharfan-Dabaja; Rami A Mahfouz; Raafat S Alameddine; Nadim M W El-Majzoub; Ziad M Salem
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

Review 2.  Diamond Blackfan anemia treatment: past, present, and future.

Authors:  Anupama Narla; Adrianna Vlachos; David G Nathan
Journal:  Semin Hematol       Date:  2011-04       Impact factor: 3.851

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  A case of pure red cell aplasia: follow-up on different immunosuppressive regimens.

Authors:  M Baldus; M Möller; H Walter; H Brass; W Queisser
Journal:  Clin Investig       Date:  1994-12

Review 5.  Acquired pure red cell aplasia: updated review of treatment.

Authors:  Kenichi Sawada; Naohito Fujishima; Makoto Hirokawa
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.